Nordson NDSN Medical and Fluid Solutions — Adjusted cost of sales
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Nordson in its filing.
Tagged under the XBRL concept ndsn:CostOfSalesAdjusted.
The official record: Nordson’s 10-Q, filed May 21, 2026, on SEC EDGAR. View the filing →
Ask your AI about Nordson's medical and fluid solutions — adjusted cost of sales.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Nordson's medical and fluid solutions — adjusted cost of sales?
- Nordson (NDSN) reported medical and fluid solutions — adjusted cost of sales of -$108.17M in Q1 2026.
- How has Nordson's medical and fluid solutions — adjusted cost of sales changed year-over-year?
- Nordson's medical and fluid solutions — adjusted cost of sales decreased by 6.7% year-over-year, from -$101.36M to -$108.17M.
- What does medical and fluid solutions — adjusted cost of sales mean?
- The direct costs associated with producing and delivering the goods sold by the Medical and Fluid Solutions segment, adjusted to exclude non-recurring or non-operational items. It includes raw materials, direct labor, and manufacturing overheads required to support medical fluid product lines.